+ Tcell-mediated immunity is the recognition of peptide-major histocompatibility complex class I (p-MHC I) proteins displayed by antigen-presenting cells. Chaperone-mediated loading of high-affinity peptides onto MHC I is a key step in the MHC I antigen presentation pathway. However, the structure of MHC I with a chaperone that facilitates peptide loading has not been determined.We report the crystal structure of MHC I in complex with the peptide editor TAPBPR (TAP-binding protein-related), a tapasin homolog. TAPBPR remodels the peptidebinding groove of MHC I, resulting in the release of low-affinity peptide. Changes include groove relaxation, modifications of key binding pockets, and domain adjustments. This structure captures a peptide-receptive state of MHC I and provides insights into the mechanism of peptide editing by TAPBPR and, by analogy, tapasin.
C ell surface peptide-major histocompatibility complex class I (p-MHC I) complexes play a crucial role in adaptive and innate immunity by functioning as ligands for immunosurveillance by CD8 + T cells and natural killer cells (1, 2) . Key to the intracellular assembly of p-MHC I complexes is the selective loading of high-affinity peptides, a process termed "peptide editing." A dynamic series of steps involving peptide binding and exchange is orchestrated in the endoplasmic reticulum (ER) by tapasin or the closely related TAPBPR (TAP-binding proteinrelated) (3) to ensure that peptides of optimal affinity and length are assembled with MHC I for display on the cell surface. Although the x-ray structure of tapasin in complex with the peptideloading complex component ERp57 has been determined (4) , structural data addressing the mechanism of peptide editing have been limited, likely because of the difficulty in generating crystallizable peptide-free (PF) or peptide-receptive (PR) MHC I. ), generated by photolysis of coassembled photosensitive peptides (5, 6) . Attempts to crystallize purified TAPBPR-MHC I complexes generated in this manner ( fig. S1 ) were unsuccessful. Thus, we developed an alternative strategy to prepare partially peptide-filled yet stable p-MHC I molecules. Previous studies of MHC I interactions with the related molecule, tapasin (7) (8) (9) (10) (11) , as well as molecular dynamics (MD) simulations (12) (13) (14) (15) (16) (17) suggest that the flexibility of the MHC I F pocket, which accommodates the C-terminal amino acid of the peptide (18) , is modulated by tapasin. Thus, we reasoned that p-MHC I molecules assembled with peptides truncated from the C terminus, leaving the F pocket unoccupied, would serve as effective ligands for TAPBPR. However, C-terminal-truncated peptides failed to efficiently refold many MHC I molecules, so we adapted an approach developed for the HLA-DM-HLA-DR1 complex (19, 20) and examined both human and mouse p-MHC I structures to identify those that would be amenable to disulfide linkage at central peptide positions (see materials and methods). By exploiting the stabilizing effect of a GL dipeptide (see materials and methods), we successfully generated D   d   73C molecules disulfide-linked to each of three peptides  (table S1) : full-length pI10C5 (RGPGCAFVTI) and two truncated versions [pA6C5 (RGPGCA) and pR5C5 (RGPGC)].
We next examined the binding of peptide-D d 73C complexes to human TAPBPR by surface plasmon resonance (SPR) (Fig. 1) . The D d 73C-10mer (10mer, 10-amino acid oligomer) bound to TAPBPR with an equilibrium constant, K D , of 0.19 mM and a dissociation rate constant, k d , of 0.024 s −1 (Fig. 1A) . By contrast, the D (Fig. 2, A to C) . The composite TAPBPR N/IgV domain, which extends from the N terminus to residue 281, consisted of 19 b strands with one short 3 10 -helix at residues 254 to 256. These b strands were structurally similar to those of tapasin in the tapasin-ERp57 complex and reflect the sequence conservation among different TAPBPR species ( fig. S4 ). The C-terminal domain (residues 282 to 377) revealed a typical IgC structure that notably forms part of an Ig domain trimer coordinating with the Ig-like b 2 m and D d 73C a3 domains (Fig. 2D) . The TAPBPR-D d 73C interface (Fig. 2, E and F (Fig. 3, A and B) . In the region of direct contact between the D d 73C-5mer and TAPBPR, the a2-1 helix was pulled away by as much as 3 Å [by interaction between residues 138 to 150 (particularly R144, R145, and E148 of D d 73C) and residues of the palm of the "glove" of the TAPBPR N/IgV domain (Fig. 3, A TAPBPR glove by as much as 1.4 Å (Fig. 3D) . Other intermolecular interactions are listed in table S3. Interaction with TAPBPR distorted the peptide-binding groove. Notably, the side chain of Y84, which canonically coordinates both the C terminus of bound peptide and K146 of a2-1, flipped away from the groove to interact with E102 of TAPBPR (Fig. 3, E and F) . The changes in this region deformed the F pocket, which normally accommodates the side chain of the C-terminal amino acid of the bound peptide. TAPBPR not only distorted the localized region of contact but also exerted distal effects on the organization of A and B pocket residues that coordinate the N terminus of the bound peptide. In two of the four molecules in the asymmetric unit, the D d 73C R66 side chain extended across the binding groove to hydrogen bond with Y159, effectively closing off this section (Fig. 3, G and H) . As a consequence of these dynamic structural changes in the binding groove, electron density for the covalently bound 5mer peptide, the GL dipeptide (used in refolding), and the accompanying peptide-stabilizing hydrogen bonding network, clearly seen in the unliganded D d 73C-5mer ( fig. S3, C, F, and G) , was no longer visualized in the TAPBPR complex. This lack of electron density of the covalently bound peptide, taken together with the widening of the groove at the F pocket region and rearrangements of key peptide-binding residues of D d 73C, is consistent with the view that the covalently bound 5mer is mobile in the complex and is no longer tethered to the binding groove.
A An unanticipated result was the identification of important contacts of TAPBPR with b 2 m. In the complex, several regions of TAPBPR-b 2 m contact were noted, including residues of the b1 strand at the N terminus of b 2 m; the loop at residues 58 to 60, which abuts the 210-to-213 loop of TAPBPR; and C-terminal residues 92 to 94 of strand b7 that bind residues 330 to 332 of the IgC domain of TAPBPR (Fig. 4, A to C) . The importance of the b 2 m 58-to-60 loop is evidenced by reduced TAPBPR binding to the D d 73C-5mer assembled with a b 2 m D59A (D59→A59) mutant (Fig. 4 , E and G to I). Ala substitutions of b 2 m residues I7 or I92/K94 do not affect TAPBPR binding as severely as D59A (Fig. 4, D and F to I) . Functional and binding studies have suggested the mutual contribution of b 2 m and bound peptide to MHC I stability (22) (23) (24) (25) . Additionally, nuclear magnetic resonance studies of MHC I reveal peptide-influenced changes in chemical shifts of the b 2 m 58-to-60 loop, which abuts the floor of the peptide-binding platform (26) . Thus, b 2 m 58-to-60 loop interactions with TAPBPR may not only stabilize PR MHC I but also communicate the occupancy of the peptidebinding groove-whether empty, partially occupied, or occupied by a low-or high-affinity peptide.
The crystal structure of the TAPBPR-D d 73C-5mer complex provides an x-ray structure of TAPBPR and permits direct comparison with the related tapasin. As implied by previous lowresolution small-angle x-ray scattering structures (6) and anticipated by mutational and MD studies (21, 27) , TAPBPR and tapasin, despite only 22% protein sequence identity, reveal marked structural similarity (Fig. 2G). Mutational analyses  (4, 6, 8, 9, 21, 28, 29) and MD simulations (12, 15, 17) , 
1.8Å mapped the general region of the tapasin-MHC I interaction to the MHC I a2-1 helix and the a3 domain, sites that overlap with the TAPBPR binding site (21) . Residues that interact with MHC I are broadly conserved between TAPBPR and tapasin ( fig. S4) . Finally, the TAPBPR-D d 73C complex structure provides a basis for building a homology model of tapasin-HLA-B*44:02 ( fig. S6 ) to guide further tests of the mechanism underlying the catalytic role of tapasin.
A comparison of the role of TAPBPR with that of HLA-DM, which similarly stabilizes a peptidereceptive conformation of the MHC II molecule, revealed that these two classes of chaperone function by destabilizing diametrically opposite regions of the binding groove: TAPBPR affects the F pocket (C-terminal portion) of the MHC I groove directly, whereas HLA-DM distorts the P1 pocket (N-terminal portion) of MHC II. Although large structural changes in HLA-DR on HLA-DM binding in the P9 region have not been observed, a clear-cut effect of P9-substituted peptides on the stability of HLA-DM-HLA-DR complexes has been noted (19) .
TAPBPR and tapasin function as both chaperones and peptide editors. As viewed through the x-ray structure of the peptide-dissociable TAPBPR-D d 73C-5mer complex described here, in which the 5mer represents a low-affinity peptide, chaperone and editor functions are the result of the same structural effects: stabilization of an MHC I conformation showing global differences in the a2-1 helix; the accessibility of the full peptidebinding groove, including the A and F pockets; and the relative disposition of the a3 and b 2 m domains. We propose a model of TAPBPRmediated peptide editing in which TAPBPR catalyzes dissociation of low-affinity peptides, stabilizes PR (empty) MHC I, and is released by high-affinity peptide (Fig. 4J) . By analogy, tapasin follows the same general structural principles.
This structural description of the interaction between MHC I and TAPBPR provides insights into the molecular mechanism of peptide editing, an evolutionarily conserved and critical step in generating stable cell surface p-MHC I complexes for immunological surveillance. Additionally, this work provides a basis for further structural and computational approaches modeling additional components of the TAPBPR-and tapasin-mediated peptide presentation pathways. . S2) , and is transported to the cell surface. This model addresses only the effects of interactions of TAPBPR with MHC I. Further experiments are needed to structurally clarify the recently described recycling pathway that employs UDP-glucose: glycoprotein glucosyltransferase 1 (UGT1) (30) .
